Chugai products

Description/ Summary: Crovalimab (RG6107) is a humanised complement inhibitor C5 monoclonal antib...

20, 2015 /PRNewswire/ -- Today, Chugai Pharma USA Inc. (CPUSA), a wholly-owned ... and early clin...

Chugai Pharmaceutical's own in-house development pipeline has one of the strongest line-ups in Ja...

For a list of Chugai's current research projects please visit: http://www.chugai-pharm.co.jp/engl...

Chugai Pharmaceutical experienced unexpected demand for the drug Actemra during the pandemic, but...